M. Conde Poole

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

M. Malim, A. Hayday, S. Irshad, 2021, The Lancet Oncology.